RESUMO
Epilepsy belongs to the most common and debilitating neurological disorders with multifactorial pathophysiology and a high level of drug resistance. Therefore, with the aim of searching for new, more effective, and/or safer therapeutics, we discovered a focused series of original hybrid pyrrolidine-2,5-dione derivatives with potent anticonvulsant properties. We applied an optimized coupling reaction yielding several hybrid compounds that showed broad-spectrum activity in widely accepted animal seizure models, namely, the maximal electroshock (MES) test and the psychomotor 6 Hz (32 mA) seizure model in mice. The most potent anticonvulsant activity and favorable safety profile was demonstrated for compound 30 (median effective dose (ED50) MES = 45.6 mg/kg, ED50 6 Hz (32 mA) = 39.5 mg/kg, median toxic dose (TD50) (rotarod test) = 162.4 mg/kg). Anticonvulsant drugs often show activity in pain models, and compound 30 was also proven effective in the formalin test of tonic pain, the capsaicin-induced pain model, and the oxaliplatin (OXPT)-induced neuropathic pain model in mice. Our studies showed that the most plausible mechanism of action of 30 involves inhibition of calcium currents mediated by Cav1.2 (L-type) channels. Importantly, 30 revealed high metabolic stability on human liver microsomes, negligible hepatotoxicity, and relatively weak inhibition of CYP3A4, CYP2D6, and CYP2C9 isoforms of cytochrome P450, compared to reference compounds. The promising in vivo activity profile and drug-like properties of compound 30 make it an interesting candidate for further preclinical development.
Assuntos
Acetamidas/farmacologia , Analgésicos/farmacologia , Anticonvulsivantes/farmacologia , Epilepsia Parcial Complexa/tratamento farmacológico , Dor/tratamento farmacológico , Pirrolidinas/farmacologia , Convulsões/tratamento farmacológico , Acetamidas/síntese química , Analgésicos/síntese química , Animais , Anticonvulsivantes/síntese química , Canais de Cálcio Tipo L/genética , Canais de Cálcio Tipo L/metabolismo , Capsaicina , Citocromo P-450 CYP2C9/genética , Citocromo P-450 CYP2C9/metabolismo , Citocromo P-450 CYP2D6/genética , Citocromo P-450 CYP2D6/metabolismo , Citocromo P-450 CYP3A/genética , Citocromo P-450 CYP3A/metabolismo , Modelos Animais de Doenças , Esquema de Medicação , Eletrochoque/métodos , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia Parcial Complexa/genética , Epilepsia Parcial Complexa/fisiopatologia , Formaldeído , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Masculino , Camundongos , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/metabolismo , Oxaliplatina , Dor/induzido quimicamente , Dor/genética , Dor/fisiopatologia , Pirrolidinas/síntese química , Teste de Desempenho do Rota-Rod , Convulsões/induzido quimicamente , Convulsões/genética , Convulsões/fisiopatologia , Relação Estrutura-AtividadeRESUMO
OBJECTIVE: Temporal lobe epilepsy is a relatively frequent, invalidating, and often refractory neurologic disorder. It is associated with cognitive impairments that affect memory and executive functions. In the rat lithium-pilocarpine temporal lobe epilepsy model, memory impairment and anxiety disorder are classically reported. Here we evaluated sustained visual attention in this model of epilepsy, a function not frequently explored. METHODS: Thirty-five Sprague-Dawley rats were subjected to lithium-pilocarpine status epilepticus. Twenty of them received a carisbamate treatment for 7 days, starting 1 h after status epilepticus onset. Twelve controls received lithium and saline. Five months later, attention was assessed in the five-choice serial reaction time task, a task that tests visual attention and inhibitory control (impulsivity/compulsivity). Neuronal counting was performed in brain regions of interest to the functions studied (hippocampus, prefrontal cortex, nucleus basalis magnocellularis, and pedunculopontine tegmental nucleus). RESULTS: Lithium-pilocarpine rats developed motor seizures. When they were able to learn the task, they exhibited attention impairment and a tendency toward impulsivity and compulsivity. These disturbances occurred in the absence of neuronal loss in structures classically related to attentional performance, although they seemed to better correlate with neuronal loss in hippocampus. Globally, rats that received carisbamate and developed motor seizures were as impaired as untreated rats, whereas those that did not develop overt motor seizures performed like controls, despite evidence for hippocampal damage. SIGNIFICANCE: This study shows that attention deficits reported by patients with temporal lobe epilepsy can be observed in the lithium-pilocarpine model. Carisbamate prevents the occurrence of motor seizures, attention impairment, impulsivity, and compulsivity in a subpopulation of neuroprotected rats.
Assuntos
Atenção , Modelos Animais de Doenças , Epilepsia Parcial Complexa/psicologia , Epilepsia do Lobo Temporal/psicologia , Função Executiva , Estado Epiléptico/psicologia , Animais , Anticonvulsivantes/farmacologia , Atenção/efeitos dos fármacos , Atenção/fisiologia , Encéfalo/efeitos dos fármacos , Encéfalo/fisiopatologia , Mapeamento Encefálico , Carbamatos/farmacologia , Contagem de Células , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia Parcial Complexa/fisiopatologia , Epilepsia do Lobo Temporal/induzido quimicamente , Epilepsia do Lobo Temporal/fisiopatologia , Função Executiva/efeitos dos fármacos , Função Executiva/fisiologia , Inibição Psicológica , Carbonato de Lítio , Neurônios/efeitos dos fármacos , Neurônios/fisiologia , Reconhecimento Visual de Modelos/efeitos dos fármacos , Reconhecimento Visual de Modelos/fisiologia , Pilocarpina , Ratos , Ratos Sprague-Dawley , Tempo de Reação/efeitos dos fármacos , Tempo de Reação/fisiologia , Aprendizagem Seriada/efeitos dos fármacos , Aprendizagem Seriada/fisiologia , Estado Epiléptico/induzido quimicamente , Estado Epiléptico/fisiopatologiaRESUMO
Complex partial seizures, which typically originate in limbic structures such as the amygdala, are often resistant to antiseizure medications. Our goal was to investigate the effects of chronic dietary supplementation with n-3 polyunsaturated fatty acids (PUFAs) derived from fish oil on seizure thresholds in the amygdala, as well as on blood and brain PUFA levels. The acute effects of injected n-3 PUFAs--eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)--were also tested in the maximal pentylenetetrazol (PTZ) seizure model. In amygdala-implanted subjects, fish oil supplementation significantly increased amygdaloid afterdischarge thresholds, as compared with controls at 3, 5, and 7 months after the start of supplementation. Fish oil supplementation also increased serum EPA and DHA concentrations. DHA concentration in the pyriform-amygdala area increased in the fish-oil treated group by 17-34%, but this effect did not reach statistical significance (P=0.065). DHA significantly increased the latency to seizure onset in the PTZ seizure model, whereas EPA had no significant effect. These observations suggest that chronic dietary fish oil supplementation can raise focal amygdaloid seizure thresholds and that this effect is likely mediated by DHA rather than by EPA.
Assuntos
Tonsila do Cerebelo/fisiopatologia , Epilepsia Parcial Complexa/dietoterapia , Epilepsia Parcial Complexa/patologia , Óleos de Peixe/administração & dosagem , Tonsila do Cerebelo/efeitos dos fármacos , Animais , Peso Corporal/efeitos dos fármacos , Peso Corporal/fisiologia , Convulsivantes/toxicidade , Modelos Animais de Doenças , Ácidos Docosa-Hexaenoicos/administração & dosagem , Relação Dose-Resposta a Droga , Esquema de Medicação , Ingestão de Alimentos/efeitos dos fármacos , Ingestão de Alimentos/fisiologia , Eletrodos Implantados , Eletroencefalografia , Epilepsia Parcial Complexa/induzido quimicamente , Ácidos Graxos/metabolismo , Ácidos Graxos Ômega-3/administração & dosagem , Seguimentos , Masculino , Pentilenotetrazol/toxicidade , Ratos , Ratos Wistar , Fatores de TempoRESUMO
A 9-year-old girl with akinetic-rigid parkinsonism with tremor is described. She was hospitalized with neuroleptic malignant syndrome that started 3 days after anticonvulsant drug treatment owing to epileptic seizures. Cranial magnetic resonance imaging (MRI) was normal, and during the follow-up, magnetic resonance spectroscopy revealed a decrement on N-acetylaspartate in the basal ganglia, suggesting neuronal dysfunction. The basal ganglia and dopamine are involved in the pathophysiology of parkinsonism and neuroleptic malignant syndrome and have been recognized in seizure propagation and seizure threshold. Parkinsonism in children is considered an acquired, secondary, and reversible disorder with a dramatic improvement to treatment. However, our patient still has parkinsonism 2 years after diagnosis. This case represents the unusual presentation of epilepsy, parkinsonism, and neuroleptic malignant syndrome, which might have a common pathophysiologic pathway (dopaminergic dysfunction) involving the basal ganglia and the hypothalamus.
Assuntos
Anticonvulsivantes/efeitos adversos , Epilepsia/tratamento farmacológico , Síndrome Maligna Neuroléptica/fisiopatologia , Transtornos Parkinsonianos/induzido quimicamente , Transtornos Parkinsonianos/fisiopatologia , Fenitoína/efeitos adversos , Antiparkinsonianos/uso terapêutico , Ácido Aspártico/análogos & derivados , Ácido Aspártico/metabolismo , Gânglios da Base/efeitos dos fármacos , Gânglios da Base/metabolismo , Gânglios da Base/fisiopatologia , Benzotiazóis/uso terapêutico , Carbamazepina/uso terapêutico , Criança , Eletroencefalografia , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia Parcial Complexa/fisiopatologia , Feminino , Humanos , Espectroscopia de Ressonância Magnética , Síndrome Maligna Neuroléptica/diagnóstico , Transtornos Parkinsonianos/diagnóstico , Pramipexol , TempoRESUMO
Several kinds of psychiatric symptoms (anxiety, depression, schizophrenia) have been associated with epilepsies, and clinical data suggest that patients with seizures involving limbic structures are the most prone to develop behavioural disorders between the seizures (i.e. interictally). Studying the neurobiological mechanisms that underlie these symptoms is difficult in humans because of different interfering factors (e.g. psychosocial difficulties, pharmacological side-effects, lesions), which can be avoided in animal models. Using repetitive electrical stimulations (kindling) or local applications of a neuroexcitotoxin in limbic structures (mainly the amygdala and hippocampus), several authors have reported lasting changes of emotional reactivity in cats and rats. These changes appear as anxiety-related reactions expressed as a hyperdefensiveness in the cat, or a reduction of spontaneous exploration in tests predictive of anxiogenic effects in the rat. Some neuroplasticity processes known to develop during epileptogenesis (neuronal-hyperexcitability, modulation of GABA/benzodiazepine transmission) may participate in these lasting changes of behaviour, especially in structures involved in the control of fear-promoted reactions (amygdala, periaqueductal grey matter). In addition, endogenous control systems may also play a critical role in the occurrence of interictal behavioural disorders.
Assuntos
Ansiedade/induzido quimicamente , Ansiedade/psicologia , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia Parcial Complexa/psicologia , Animais , Ansiedade/fisiopatologia , Modelos Animais de Doenças , Epilepsia Parcial Complexa/fisiopatologia , Humanos , Convulsões/fisiopatologiaRESUMO
The goal of the present study was to determine whether alumina gel injections into temporal lobe structures cause complex partial seizures (CPS) and pathological changes observed in human temporal lobe epilepsy. Rhesus monkeys with alumina gel injections in the amygdala, perirhinal and entorhinal cortices, or Ammon's horn and dentate gyrus all initially displayed focal pathological electroencephalographic (EEG) slowing limited to the site of injection. After clinical seizures developed, they also displayed widespread pathological EEG slowing over both hemispheres, interictal and ictal epileptiform EEG abnormalities limited to the mesial-inferior temporal lobe on the side of injection, and different degrees of spread to other ipsilateral and contralateral structures. Noninjected control and nonepileptic monkeys with injections into the middle and inferior temporal gyri displayed no hippocampal neuronal loss or mossy fiber sprouting. When alumina gel was injected into the amygdala, CPS began within 3-6 weeks and degeneration of neurons and gliosis occurred in the perirhinal cortex or the hippocampus, with consequent sprouting of mossy fibers in the dentate gyrus. Dispersion of the granule cell layer was also observed. Other monkeys with alumina gel in the perirhinal and entorhinal cortices developed CPS within 2-3 weeks after the injections and displayed mossy fiber sprouting only after 4 weeks after the injections. Alumina gel in Ammon's horn and the dentate gyrus also induced CPS, but mossy fiber sprouting was limited to sites immediately adjacent to the injection, probably because none survived more than 4 weeks after the injections. This nonhuman primate model of CPS displayed similar anatomical, behavioral, and EEG features as observed in human temporal lobe epilepsy and provides opportunities to analyze the chronological sequence of epileptogenesis and to test potential therapies.
Assuntos
Epilepsia Parcial Complexa/fisiopatologia , Epilepsia do Lobo Temporal/fisiopatologia , Macaca mulatta/fisiologia , Lobo Temporal/fisiopatologia , Óxido de Alumínio , Tonsila do Cerebelo/citologia , Tonsila do Cerebelo/fisiopatologia , Animais , Giro Denteado/citologia , Giro Denteado/fisiopatologia , Eletroencefalografia , Córtex Entorrinal/citologia , Córtex Entorrinal/fisiopatologia , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia do Lobo Temporal/induzido quimicamente , Géis , Humanos , Masculino , Microscopia Eletrônica , Fibras Musgosas Hipocampais/fisiologia , Fibras Musgosas Hipocampais/ultraestrutura , Coloração e Rotulagem , Lobo Temporal/citologiaRESUMO
Sprouting of mossy fibers in the hippocampus of rats that underwent limbic epileptogenesis by amygdala kindling or kainate injection was studied at the light microscopic and ultrastructural levels by cytochemical demonstration of the enzyme 5'-nucleotidase. This adenosine-producing ectoenzyme has previously been shown to characterize malleable terminals during brain development and lesion-induced synaptogenesis, but to be otherwise associated with glial membranes. At the light microscopic level, kainate-treated but not control or kindled rats showed 5'-nucleotidase activity in the CA3 region and in the inner molecular layer of the dentate gyrus. At the ultrastructural level, in control animals, the synapses of the molecular and granular layers were enzyme negative. Only some mossy fiber boutons of the dentate hilus exhibited 5'-nucleotidase activity. In epileptic rats, synaptic labeling within the hilus appeared more intense. Moreover, 5'-nucleotidase-containing terminals within the inner molecular layer, presumably ectopic mossy fiber boutons, were found in both kindled and kainate-treated rats. It is concluded that, in both the normal and epileptic hippocampus, 5'-nucleotidase is associated with axons capable of a plastic sprouting response. The synaptic enzyme may attenuate the glutamatergic transmission of mossy fibers, in particular of the aberrant mossy fibers in epileptic rats, by producing the inhibitory neuromodulator adenosine. Alternatively, 5'-nucleotidase may influence synapse formation by its putative non-enzymatic, adhesive functions.
Assuntos
5'-Nucleotidase/metabolismo , Giro Denteado/citologia , Giro Denteado/enzimologia , Epilepsia Parcial Complexa/enzimologia , Fibras Musgosas Hipocampais/enzimologia , Tonsila do Cerebelo/fisiologia , Animais , Giro Denteado/patologia , Estimulação Elétrica , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia Parcial Complexa/patologia , Agonistas de Aminoácidos Excitatórios , Feminino , Histocitoquímica , Ácido Caínico , Microscopia Eletrônica , Fibras Musgosas Hipocampais/patologia , Fibras Musgosas Hipocampais/ultraestrutura , Ratos , Ratos WistarRESUMO
1. The tetanus toxin seizure model, which is associated with spontaneous and intermittent generalized and non-generalized seizures, is considered to reflect human complex partial epilepsy. The purpose of the present study was to investigate and compare the anticonvulsant effects of carbamazepine with that of levetiracetam, a new anti-epileptic drug in this model. 2. One microl of tetanus toxin solution (containing 12 mLD(50) microl(-1) of tetanus toxin) was placed stereotactically into the rat left hippocampus resulting in generalized and non-generalized seizures. 3. Carbamazepine (4 mg kg(-1) h(-1)) and levetiracetam (8 and 16 mg kg(-1) h(-1)) were administered during a 7 day period via an osmotic minipump which was placed in the peritoneal cavity. Carbamazepine (4 mg kg(-1) h(-1)) exhibited no significant anticonvulsant effect, compared to control, when the entire 7 day study period was evaluated but the reduction in generalized seizures was greater (35.5%) than that for non-generalized seizures (12.6%). However, during the first 2 days of carbamazepine administration a significant reduction in both generalized seizure frequency (90%) and duration (25%) was observed. Non-generalized seizures were unaffected. This time-dependent anticonvulsant effect exactly paralleled the central (CSF) and peripheral (serum) kinetics of carbamazepine in that steady-state concentrations declined over time, with the highest concentrations achieved during the first 2 days. Also there was a significant 27.3% reduction in duration of generalized seizures during the 7 day study period (P=0.0001). 4. Levetiracetam administration (8 and 16 mg kg(-1) h(-1)) was associated with a dose-dependent reduction in the frequency of both generalized (39 v 57%) and non-generalized (36 v 41%) seizures. However, seizure suppression was more substantial for generalized seizures. Also a significant dose-dependent reduction in overall generalized seizure duration was observed. 5. These data provide experimental evidence for the clinical efficacy of levetiracetam for the management of patients with complex partial seizures. Furthermore, levetiracetam probably does not act by preventing ictogenesis per se but acts to reduce seizure severity and seizure generalization.
Assuntos
Anticonvulsivantes/uso terapêutico , Carbamazepina/uso terapêutico , Epilepsia Parcial Complexa/tratamento farmacológico , Piracetam/análogos & derivados , Piracetam/uso terapêutico , Toxina Tetânica/toxicidade , Animais , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia Parcial Complexa/fisiopatologia , Levetiracetam , Masculino , Ratos , Ratos Sprague-DawleyRESUMO
An animal model of human complex partial status epilepticus induced by lithium chloride and pilocarpine administration was developed in our laboratory. The objective of the study was to provide a detailed analysis of both ictal and postictal behavior and to quantify seizure-related morphological damage. In order to determine the animal's responsiveness to either visual or olfactory stimuli, adult male rats were submitted to the following behavioral paradigms: the object response test, the social interaction test, and the elevated plus-maze test. The rotorod test was used to evaluate motor performance. Two weeks after status epilepticus, brains were morphologically examined and quantification of the brain damage was performed. Profound impairment of behavior as well as responsiveness to exteroceptive stimuli correlated with the occurrence of epileptic EEG activity. When the epileptic EEG activity ceased, responsiveness of the pilocarpine-treated animals was renewed. However, remarkable morphological damage persisted in the cortical regions two weeks later. This experimental study provides support for the clinical evidence that even nonconvulsive epileptic activity may cause brain damage. We suggest that the model can be used for the study of both functional and morphological consequences of prolonged nonconvulsive seizures.
Assuntos
Comportamento Animal/efeitos dos fármacos , Encéfalo/patologia , Epilepsia Parcial Complexa , Lítio/farmacologia , Agonistas Muscarínicos/farmacologia , Pilocarpina/farmacologia , Estado Epiléptico , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/fisiopatologia , Modelos Animais de Doenças , Eletroencefalografia , Epilepsia Parcial Contínua , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia Parcial Complexa/patologia , Epilepsia Parcial Complexa/fisiopatologia , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Córtex Motor/patologia , Equilíbrio Postural/efeitos dos fármacos , Distribuição Aleatória , Ratos , Ratos Wistar , Comportamento Social , Estado Epiléptico/induzido quimicamente , Estado Epiléptico/patologia , Estado Epiléptico/fisiopatologiaRESUMO
The authors describe three cases of partial complex epileptic seizures precipitated by alcohol consumption. No other causative factor was found. Brain imaging was normal. The role of alcohol in precipitating this type of seizures is discussed.
Assuntos
Consumo de Bebidas Alcoólicas/efeitos adversos , Epilepsia Parcial Complexa/induzido quimicamente , Adulto , Eletroencefalografia , Epilepsia Parcial Complexa/fisiopatologia , Feminino , Humanos , Fatores de RiscoRESUMO
Pilocarpine (PILO) induces in rats limbic seizures that become secondarily generalized and evolve to status epilepticus (SE). Spontaneous recurrent seizures are registered during the long-term period following the systemic administration of PILO in rats. EEG, behavioral, and pathological features resemble those of complex partial seizures. The antiepileptic drugs (AEDs) diazepam, phenobarbital (PB), valproic acid (VPA) and trimethadione protect against PILO-induced SE while phenytoin (PHT) and carbamazepine (CBZ) are ineffective. Studies with AEDs on spontaneous seizures (chronic period) of this model have not yet been established. We now report the effects of different AEDs on spontaneous seizures. Male Wistar rats were subjected to PILO-induced SE. Following recovery from SE animals were daily observed in order to detect spontaneous seizures and to establish the baseline seizure frequency. PB 40 mg/kg, PHT 100 mg/kg, CBZ 120 mg/kg, VPA (450 mg/kg and 600 mg/kg) and ethosuximide (ETX) 400 mg/kg were given daily to epileptic rats for two weeks during the spontaneous recurrent seizures period. PB, CBZ and PHT were effective against spontaneous seizures. VPA was also effective against spontaneous seizures at the dose of 600 mg/kg and ETX was inactive against these seizures. Such pharmacological profiles correlate well with complex partial seizures. The results indicate that spontaneous recurrent seizures after PILO-induced SE may be a useful model for finding new AEDs with better efficacy against complex partial seizures. The use of animal models that share both pharmacological and phenomenological features with human epilepsy might improve their predictive value for specific types of human epilepsy.
Assuntos
Anticonvulsivantes/uso terapêutico , Convulsões/tratamento farmacológico , Animais , Modelos Animais de Doenças , Eletroencefalografia/efeitos dos fármacos , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia Parcial Complexa/tratamento farmacológico , Masculino , Pilocarpina , Ratos , Ratos Wistar , Recidiva , Convulsões/induzido quimicamente , Estado Epiléptico/induzido quimicamenteRESUMO
Phenytoin has been reported to exert variable anticonvulsant effects in the kindling model of complex partial seizures. Phenytoin is only water soluble at a pH of more than 10, and it has been suspected that poor absorption of the drug is responsible for its lack of effect in some experiments. Recently, fosphenytoin, a prodrug of phenytoin, has been developed by phosphorylating phenytoin which makes the drug water soluble at physiological pH while it is rapidly transformed to phenytoin after injection. This study examined the anticonvulsant profile and the absorption after intraperitoneal injection of fosphenytoin, compared to its parental drug phenytoin. The pharmacokinetic parameters of phenytoin and fosphenytoin were compared by determining plasma levels of phenytoin after i.p. injection of 50 mg/kg phenytoin or the equivalent dose of 84 mg/kg of fosphenytoin in non-kindled female Wistar rats. After both injections the maximal plasma concentration of phenytoin was about 30 microg/ml. The relative bioavailability of fosphenytoin was 83%. In contrast to phenytoin, failed injections resulting in non-detectable plasma concentration of phenytoin were almost absent after fosphenytoin. In fully kindled female Wistar rats, fosphenytoin dose-dependently increased the focal seizure (afterdischarge) threshold. Seizure severity and duration at threshold were reduced only after the highest does of fosphenytoin tested (84 mg/kg). Thus, fosphenytoin showed anticonvulsant properties similar to phenytoin in amygdala kindled rats. We conclude that fosphenytoin is an adequate and reliable substitute for the parenteral injection of phenytoin in experimental seizure models of rats.
Assuntos
Tonsila do Cerebelo/efeitos dos fármacos , Anticonvulsivantes/farmacologia , Epilepsia Parcial Complexa/tratamento farmacológico , Excitação Neurológica/fisiologia , Fenitoína/análogos & derivados , Fenitoína/farmacologia , Tonsila do Cerebelo/fisiologia , Tonsila do Cerebelo/fisiopatologia , Animais , Anticonvulsivantes/farmacocinética , Disponibilidade Biológica , Relação Dose-Resposta a Droga , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia Parcial Complexa/fisiopatologia , Feminino , Excitação Neurológica/efeitos dos fármacos , Fenitoína/farmacocinética , Pró-Fármacos/farmacocinética , Pró-Fármacos/farmacologia , Ratos , Ratos WistarAssuntos
Acetamidas/efeitos adversos , Anti-Infecciosos/efeitos adversos , Epilepsia Parcial Complexa/induzido quimicamente , Oxazolidinonas/efeitos adversos , Acetamidas/uso terapêutico , Idoso , Anti-Infecciosos/uso terapêutico , Epilepsia/tratamento farmacológico , Humanos , Levetiracetam , Linezolida , Masculino , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Oxazolidinonas/uso terapêutico , Piracetam/análogos & derivados , Piracetam/uso terapêutico , Infecções Estafilocócicas/tratamento farmacológico , Úlcera/tratamento farmacológico , Úlcera/microbiologiaRESUMO
The objective of this study was to evaluate whether water apparent diffusion coefficient (ADC) measurements provide more specific information than T2-weighted MRI about the evolution of brain parenchyma lesions secondary to prolonged complex partial seizures. We measured the ADC in the brain of rats exhibiting prolonged complex partial seizures induced by intraperitoneal injection of kainic acid (KA). The animals were imaged with diffusion and T2-weighted MRI at 2 T from 3 h up to 9 days after KA injection. In the piriform cortex and amygdala, the T2-weighted MRI signal intensity appeared to be uniformly increased from 24 to 72 h after KA injection, and returned to normal by 9 days. In the same regions between 24 and 72 h, the ADC first decreased and then increased. The ADC changes were consistent with the known histopathologic alterations. In this complex partial seizure model, the ADC measurement provides more specific information than T2-weighted MRI about the histopathologic evolution of the lesions. This supports the proposal that diffusion MRI may be valuable for the evaluation of the neuropathologic sequelae in patients with multiple or prolonged seizures.
Assuntos
Encéfalo/patologia , Epilepsia Parcial Complexa/diagnóstico , Imageamento por Ressonância Magnética , Estado Epiléptico/diagnóstico , Animais , Epilepsia Parcial Complexa/induzido quimicamente , Ácido Caínico , Masculino , Ratos , Ratos Sprague-Dawley , Estado Epiléptico/induzido quimicamenteRESUMO
A 10-year-old girl is described with pure photosensitive complex partial seizures which consisted of a frightening visual phenomenon of seeing "shadow people," then staring blankly with lip smacking and sometimes becoming limp. The seizures were triggered by bright sunlight. With the institution of phenytoin therapy, her seizure frequency increased dramatically without any clinical evidence of toxicity and her phenytoin blood levels were within the therapeutic range. Discontinuation of phenytoin led to a return to baseline seizure frequency. The mechanism by which antiepileptic drugs may aggravate seizures is still not understood; therefore, awareness of this phenomenon is crucial for early diagnosis and appropriate treatment.
Assuntos
Epilepsia Parcial Complexa/etiologia , Fenitoína/efeitos adversos , Luz Solar/efeitos adversos , Animais , Criança , Modelos Animais de Doenças , Eletroencefalografia , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia Parcial Complexa/epidemiologia , Feminino , Humanos , Incidência , Deficiência Intelectual/complicações , PapioRESUMO
A 49-year-old man was treated with cisplatin and pirarubicin for tongue cancer. After the second course of chemotherapy, partial seizures including transient motor aphasia, tonic finger movement, and loss of consciousness were observed. The EEG showed frequent diffuse (multiple) spike and slow wave discharges. Following the administration of carbamazepine and diazepam, no seizures occurred and no paroxysmal discharges were observed or EEGs. We conclude that carbamazepine and diazepam administration was effective.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Cisplatino/efeitos adversos , Epilepsia Parcial Complexa/induzido quimicamente , Antibióticos Antineoplásicos/administração & dosagem , Cisplatino/administração & dosagem , Doxorrubicina/administração & dosagem , Doxorrubicina/análogos & derivados , Eletroencefalografia , Epilepsia Parcial Complexa/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias da Língua/tratamento farmacológicoRESUMO
Magnetic resonance imaging before, during, and after kainic acid (KA)-induced limbic seizure status in cats demonstrated the bilateral hippocampi as slightly high-intensity areas on the T2-weighted images during the limbic seizure status, and isointensity areas 1-2 weeks after KA injection when the limbic seizure status subsided. However, the hippocampi again became high-intense 1-3 months after KA injection. Histological study suggested that the high-intensity area during the limbic seizure status resulted from regional edema, and in the chronic period from marked gliosis and/or atrophic change as a consequence of tissue damage in the hippocampus.
Assuntos
Epilepsia Parcial Complexa/induzido quimicamente , Hipocampo/efeitos dos fármacos , Ácido Caínico/farmacologia , Imageamento por Ressonância Magnética , Tonsila do Cerebelo/efeitos dos fármacos , Tonsila do Cerebelo/patologia , Animais , Gatos , Esclerose Cerebral Difusa de Schilder/induzido quimicamente , Esclerose Cerebral Difusa de Schilder/patologia , Epilepsia Parcial Complexa/patologia , Hipocampo/patologia , Lobo Temporal/efeitos dos fármacos , Lobo Temporal/patologiaRESUMO
Using alpha- and beta- tubulin cDNA Probes and Northern blot hybridization technique, we analyzed the effect of intraperitoneally injected Qingyangshen (QYS), a traditional Chinese medicine with antiepileptic property, and diphenylhydrantoin sodium (DPH) on hippocampal alpha- and beta-tubulin gene expression during kainic acid (KA) induced chronic seizures. It was found that: 1) thirty days after intraperitoneal injection of KA, alpha- and beta-tubulin mRNAs in animals showing chronic seizures increased 3.02 +/- 1.05 and 4.07 +/- 1.32 times respectively compared with control; 2) neither QYS (15 mg/kg, q.o.d. x 6) nor DPH (50 mg/kg, q.o.d. x 6), when used separately, could inhibit the above mentioned effect of KA; 3) when QYS (15 mg/kg, q.o.d. x 6) and DPH (50 mg/kg, q.o.d. x 6) were given in combination, the long-term increase in tubulin gene expression induced by KA was significantly reduced, with alpha- and beta-tubulin mRNAs being decreased to 0.44 +/- 0.08 and 0.50 x 0.10 times of corresponding values in animals treated with KA alone. The results indicate that the mechanism of antiepileptic effect of QYS is at least partially related to the inhibition of tubulin synthesis and subsequent reduction in mossy fiber sprouting and neosynaptogenesis.
Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Epilepsia Parcial Complexa/tratamento farmacológico , Hipocampo/metabolismo , Tubulina (Proteína)/genética , Animais , Sondas de DNA , DNA Complementar , Epilepsia Parcial Complexa/induzido quimicamente , Epilepsia Parcial Complexa/genética , Expressão Gênica , Ácido Caínico , Masculino , Fenitoína/uso terapêutico , RNA Mensageiro/análise , Ratos , Ratos Wistar , Tubulina (Proteína)/biossínteseRESUMO
Stereotactic surgery was performed in Wistar rats and stainless steel injection chemitrode were inserted in bilateral amygdala (AM). Stainless steel screws were placed on the dura over bilateral motor cortex (Cx). One week after the surgery, rats were placed in the recording chamber. Kainic acid (KA) injection was performed into the left AM and focal AM seizure status was induced. Seizures evolved into limbic seizure status during 3 days. Seven days after the first KA injection, KA was injected into the right AM. The limbic seizure status was elicited again, however, these seizures subsided within 3 days. About 3 week after the first KA injection, spontaneous limbic seizures developed. Three ictal EEG patterns were seen (1) Bilateral independent seizures, (2) Synchronous ictal discharge over the bilateral AM, and (3) Switch of lateralized ictal activity from one to the other AM. The histological study demonstrated bilateral hippocampal cell loss and hippocampal atrophy. These changes are very similar to those observed in human intractable complex partial seizures with bilateral mesial temporal focus. The result suggests that this model will be a good tool in order to resolve intractability of complex partial seizure in patients with bilateral temporal focus.
Assuntos
Encéfalo/patologia , Epilepsia Parcial Complexa/fisiopatologia , Animais , Modelos Animais de Doenças , Eletroencefalografia , Eletrofisiologia , Epilepsia Parcial Complexa/induzido quimicamente , Humanos , Injeções , Ácido Caínico , Masculino , Ratos , Ratos WistarRESUMO
Of 71 acute lymphoblastic leukemia survivors at our hospital over the past 10 years, 2 children developed mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS). This is the first report to describe the clinical course of MTLE-HS observed longitudinally by EEG and MRI. Patient 1 experienced a seizure during chemotherapy involving intrathecal methotrexate. Postseizure MRI suggested methotrexate encephalopathy or leukemic invasion. Anticonvulsant therapy was initiated; subsequent EEGs and MRIs revealed normal results. Three years after chemotherapy, a diffuse, irregular spike-and-wave pattern was observed on interictal EEG. Five years after chemotherapy, the patient developed MTLE-HS comprising complex partial seizures, typical temporal spikes on EEG, and hippocampal sclerosis (HS). Patient 2 did not experience seizures during chemotherapy. Four years later, the patient started experiencing complex partial seizures, and a diffuse, irregular spike-and-wave pattern was observed on interictal EEG. A clinical picture of MTLE-HS developed 2 years later. In both patients, nonspecific EEG abnormalities (ie, diffuse, irregular spike-and-wave activity) preceded the appearance of HS on MRI by 2 years, suggesting an insidious advance of HS during the latent period. Such atypical EEG findings may indicate MTLE-HS during follow-up of leukemia patients. MTLE-HS develops several years after an initial precipitating incident such as prolonged seizures, central nervous system infection, and brain trauma. In our cases, the initial precipitating incident may have been chemotherapy and/or prolonged seizures. Thus, MTLE-HS associated with leukemia may not be as rare as generally believed. A large cohort study of late neurologic complications is warranted.